Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Validity of Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer (EC)

NCT02834988 is registered in ClinicalTrials.gov with University of Miami as lead sponsor.

NCT NCT02834988
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02834988 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Validity of Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer (EC)
Lead sponsor
University of Miami
Phase
Observational
Overall status
Completed
Start date
July 28, 2016
Completion date
February 10, 2020
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer